JD HEALTH INTL LTD (8ZN) - Net Assets

Latest as of June 2025: €57.98 Billion EUR

Based on the latest financial reports, JD HEALTH INTL LTD (8ZN) has net assets worth €57.98 Billion EUR as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€78.46 Billion) and total liabilities (€20.48 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€57.98 Billion
% of Total Assets	73.89%
Annual Growth Rate	N/A
5-Year Change	40.74%
10-Year Change	N/A
Growth Volatility	4.39

JD HEALTH INTL LTD - Net Assets Trend (2019–2024)

This chart illustrates how JD HEALTH INTL LTD's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for JD HEALTH INTL LTD (2019–2024)

The table below shows the annual net assets of JD HEALTH INTL LTD from 2019 to 2024.

Year	Net Assets	Change
2024-12-31	€55.24 Billion	+11.89%
2023-12-31	€49.37 Billion	+10.24%
2022-12-31	€44.78 Billion	+12.37%
2021-12-31	€39.85 Billion	+1.54%
2020-12-31	€39.25 Billion	+8650.91%
2019-12-31	€-459.03 Million	--

Equity Component Analysis

This analysis shows how different components contribute to JD HEALTH INTL LTD's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1185534900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	€68.46 Billion	123.94%
Total Equity	€55.23 Billion	100.00%

JD HEALTH INTL LTD Competitors by Market Cap

The table below lists competitors of JD HEALTH INTL LTD ranked by their market capitalization.

Company	Market Cap
Merck KGaA XETRA:MRK	$17.91 Billion
MERCK Kommanditgesellschaft auf Aktien IL:0O14	$17.92 Billion
Telkom Indonesia (Persero) Tbk PT JK:TLKM	$17.99 Billion
OMV Aktiengesellschaft VI:OMV	$18.01 Billion
Divi's Laboratories Limited NSE:DIVISLAB	$17.88 Billion
Publicis Groupe SA PA:PUB	$17.87 Billion
Somnigroup International Inc. NYSE:SGI	$17.84 Billion
NN Group NV AS:NN	$17.82 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in JD HEALTH INTL LTD's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 49,355,752,000 to 55,231,156,000, a change of 5,875,404,000 (11.9%).
Net income of 4,161,844,000 contributed positively to equity growth.
Other factors increased equity by 1,713,560,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€4.16 Billion	+7.54%
Other Changes	€1.71 Billion	+3.1%
Total Change	€-	11.90%

Book Value vs Market Value Analysis

This analysis compares JD HEALTH INTL LTD's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.30x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2019-12-31	€-0.15	€5.20	x
2020-12-31	€12.33	€5.20	x
2021-12-31	€12.48	€5.20	x
2022-12-31	€14.08	€5.20	x
2023-12-31	€15.48	€5.20	x
2024-12-31	€17.27	€5.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently JD HEALTH INTL LTD utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.54%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.16%
• Asset Turnover: 0.82x
• Equity Multiplier: 1.29x
Recent ROE (7.54%) is above the historical average (-5.65%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2019	0.00%	-8.96%	1.25x	0.00x	€-925.90 Million
2020	-43.91%	-88.92%	0.44x	1.12x	€-21.16 Billion
2021	-2.69%	-3.50%	0.64x	1.20x	€-5.06 Billion
2022	0.85%	0.81%	0.76x	1.37x	€-4.10 Billion
2023	4.34%	4.00%	0.83x	1.30x	€-2.79 Billion
2024	7.54%	7.16%	0.82x	1.29x	€-1.36 Billion

Industry Comparison

This section compares JD HEALTH INTL LTD's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

Industry: Pharmaceutical Retailers
Average net assets among peers: $3,240,200,667
Average return on equity (ROE) among peers: -5.85%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
JD HEALTH INTL LTD (8ZN)	€57.98 Billion	0.00%	0.35x	$17.90 Billion
YSB Inc. (B1S)	$-4.37 Billion	0.00%	0.00x	$413.02 Million
Redcare Pharmacy NV (RDC)	$18.08 Million	-15.66%	0.42x	$815.28 Million
Alibaba Health Information Technology Limited (TWY)	$14.07 Billion	-1.89%	0.36x	$9.73 Billion

About JD HEALTH INTL LTD

F:8ZN Germany Pharmaceutical Retailers

Market Cap

$19.45 Billion

€16.64 Billion EUR

Market Cap Rank

#1270 Global

#208 in Germany

Share Price

€5.20

Change (1 day)

-3.08%

52-Week Range

€3.98 - €7.70

All Time High

€22.34